Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Routine Administration of Surfactant/Budesonide to Prevent BPD in VLBW With RDS-A Double Blind Study

NCT03275415 is registered in ClinicalTrials.gov with Taipei Medical University as lead sponsor.

NCT NCT03275415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03275415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Routine Administration of Surfactant/Budesonide to Prevent BPD in VLBW With RDS-A Double Blind Study
Lead sponsor
Taipei Medical University
Phase
Phase 4
Overall status
Completed
Start date
July 1, 2019
Completion date
June 30, 2022
Enrollment
310 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia, respiratory distress syndrome